New weight loss drug decreases appetite without nausea — and can even burn calories
Scientists from the University of Copenhagen say they have developed a drug that decreases appetite while increasing calorie burning — without any signs of nausea.
Weight-loss drugs can help stroke survivors prevent recurrence
The weight-loss drug Ozempic can help reduce stroke patients' risk of a heart attack or death, a new study says.
Weight loss drugs Ozempic and Wegovy may also curb alcohol addiction, study says
A study published Wednesday suggests a surprising side effect of GLP-1 drugs such as Ozempic: they can be effective at curbing alcohol abuse.
Medicaid covers GLP-1 weight-loss drugs in just 13 states
Only 13 states currently allow Medicaid to cover treatment of obesity using glucagon-like peptide-1 agonist (GLP-1) medications, researchers said.
New weight loss drug could be a 'better Ozempic'
Weather conditions complicating efforts to get New Jersey wildfire under control Deion Sanders imposed harsh punishment on Colorado players after they disregarded his game plan Princess Kate Revived Queen Elizabeth’s Remembrance Day Tradition The unhealthiest fast-food sandwich in America isn't a Big Mac,
New weight loss drug target reduces appetite and burns calories without sickness
The discovery could lead to a new treatment for millions of people with obesity and type 2 diabetes who do not respond well to current treatments.
Compounded GLP-1s for Weight Loss: What Are They and Are They Safe?
GLP-1s (glucagon-like peptide-1 receptor agonists) are medications used to treat type 2 diabetes and obesity. You’ve probably ...
FoodBusinessNews3h
Hershey acknowledges ‘mild impact’ from GLP-1 drugs
HERSHEY, PA. — GLP-1 weight-loss drugs are having a “mild impact” on The Hershey Co.’s business, president and chief ...
TCTMD1d
Many Patients Quit Taking GLP-1 Drugs: Understanding Why Is Key
In addition to ensuring equitable access to the glucagon-like peptide-1 (GLP-1 ... interest in these ...
Crain's Chicago Business12d
Endevica bets it has a weight-loss drug to beat GLP-1s with spinoff
A new Northbrook pharma will work to bring its obesity treatment to market that it says holds advantages over Ozempic and its ...
Surging diabetes rate underscores vast opportunity in weight-loss drugs
The number of adults diagnosed with diabetes has more than quadrupled since 1990 and now stands above 800 million, according ...
MedPage Today on MSN3d
ObesityWeek Roundup: Patients More Likely to Ration Weight-Loss Drugs
SAN ANTONIO -- Research presented at the ObesityWeek annual meeting included studies on rationing of prescription medications ...
Health Rounds: No need to stop GLP-1 drugs before surgery for most patients
In a practice-changing guideline reversal, medical societies advised on Tuesday that most patients do not need to stop taking ...
Hosted on MSN23h
Hims & Hers launches GLP-1 drug shortage tracker
Hims & Hers (NYSE:HIMS) has launched an online GLP-1 supply tracker where people can share information about where the ...